Mazzacco Catherine 4
4 · Krystal Biotech, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Mazzacco Catherine
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+13,600→ 13,600 totalExercise: $80.06Exp: 2033-03-31→ Common Stock (13,600 underlying)
Footnotes (1)
- [F1]The options were awarded on March 31, 2023 and vest in equal monthly tranches over a three-year period.